Evidence map›Paper›PMID 41162854›Full record

ArticleMolecular medicine (Cambridge, Mass.)2025

Molecular mechanisms of α-syn abnormal phase separation in cognitive impairment induced by chronic intermittent hypoxia and the neuroprotective effects of Danshensu methyl ester.

Juan Li, Na Zhang, Ziyin Zhang, Jinsai Fu, Wenjing Ren, Yi Sun, Shuling Song, Xiaoqian Liu, Jinghui Liu, Jingyu Wang and 8 more

Erratum issuedAbstract read
In one paragraph

Article in Molecular medicine (Cambridge, Mass.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

18 authors.

Juan Li *Department of Respiratory Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, 256603, China.
Na Zhang *Department of Respiratory Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, 256603, China.
Ziyin Zhang *Department of Respiratory Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, 256603, China.
Jinsai Fu *Department of Respiratory Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, 256603, China.
Wenjing RenDepartment of Respiratory Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, 256603, China.
Yi SunSchool of Basic Medical Sciences, Binzhou Medical University, Yantai, 264003, China.
Shuling SongSchool of Basic Medical Sciences, Binzhou Medical University, Yantai, 264003, China.
Xiaoqian LiuDepartment of The Second School of Clinical Medicine, Binzhou Medical University, Yantai, 264003, China.
Jinghui LiuDepartment of The Second School of Clinical Medicine, Binzhou Medical University, Yantai, 264003, China.
Jingyu WangDepartment of Respiratory Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, 256603, China.
Yunliang SunDepartment of Respiratory Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, 256603, China.
Kai ZhangDepartment of Respiratory Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, 256603, China.
Rongrong GuoDepartment of Respiratory Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, 256603, China.
Changjun LvDepartment of Respiratory Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, 256603, China.
Lei PanDepartment of Respiratory Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, 256603, China. panlei427@aliyun.com.
Guiwu QuSchool of Pharmacy, Binzhou Medical University, Yantai, 264003, China. quguiwu@aliyun.com.
Fang HanDepartment of Respiratory Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, 256603, China. hanfangtuandui@aliyun.com.
Yan YuDepartment of Respiratory Medicine, Binzhou Medical University Hospital, Binzhou Medical University, Binzhou, 256603, China. sleep@bzmc.edu.cn.

Funding

National Natural Science Foundation of China 82200109National Natural Science Foundation of China 82370092Natural Science Foundation of Shandong Province ZR2020MH131Natural Science Foundation of Shandong Province ZR2021MH360Youth Innovation and Technology Support Program in Colleges and Universities of Shandong Province 2022KJ090
6 · The paper itself

Abstract

The pathological association between α-synuclein (α-syn) deposition and neurodegeneration or cognitive dysfunction has been extensively studied for decades, but significant progress has yet to be achieved in clinical translation. Recently, the introduction of phase separation theory has provided a new perspective for elucidating the molecular mechanisms of α-syn deposition. We made the first discovery that chronic intermittent hypoxia (CIH) exposure induced fear memory deficits by damaging dopaminergic neurons in the ventral tegmental area (VTA). In vivo experiments showed that CIH exposure significantly increased α-syn expression and caused its abnormal deposition in the VTA, leading to neuron dysfunction. Furthermore, inhibiting α-syn expression effectively mitigated neuronal damage and fear memory deficits. Using an intermittent hypoxia (IH) model, we found that abnormal phase separation of α-syn mediates the transition from soluble state to fibrous state, which is the core mechanism of its deposition. α-syn phase separation is regulated by various factors, and we focused on reactive oxygen species (ROS), which were closely associated with α-syn liquid-liquid phase separation (LLPS) and notably altered in CIH/IH conditions. The results showed that CIH-induced ROS promoted the conversion of α-syn-EGFP phase separation droplets to fibrillar state. Moreover, in vitro experiments confirmed that hydrogen peroxide (H₂O₂) treatment induced abnormal phase separation of α-syn, while the antioxidant monomer drug Danshensu methyl ester (DME) effectively inhibited this process. Furthermore, in CIH and IH models, DME intervention significantly reduced ROS levels, inhibited α-syn abnormal phase separation, decreased intraneuronal α-syn deposition, and ultimately improved dopaminergic neuron damage and cognitive function. This study reveals that ROS-regulated abnormal phase separation of α-syn is a novel mechanism underlying CIH-induced neuron damage and might provide insights for the clinical treatment of related cognitive disorders.

Indexed as

alpha-SynucleinCognition DisordersHypoxiaLactatesNeuroprotective AgentsAnimalsDisease Models, AnimalDopaminergic NeuronsMalePhase SeparationReactive Oxygen Species3,4-dihydroxyphenyllactic acidalpha-SynucleinLactatesNeuroprotective AgentsReactive Oxygen SpeciesChronic intermittent hypoxiaDanshensu methyl esterLiquid-liquid phase separationObstructive sleep apneaReactive oxygen speciesΑ-synuclein

Identifiers

PMID41162854
PMCPMC12570643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.